Last Updated : Monday, February 3, 2020 12:41:02

Tag Archives: Drug Controller General of India

ZYDUS CADILA’s Diabetic treatment drug gets nod from Indian Drug Regulator

AHMEDABAD | MUMBAI | RAJKOT – In a regulatory update submitted to the Indian Stock Exchanges, Ahmedabad headquartered Dr Pankaj Patel led Zydus Group company Cadila Healthcare Ltd said of having got approval from Drug Controller General of India (DCDI) for Saroglitazar Magnesium for treatment of diabetes. To read more, please CLICK here. Long Read

India’s First New Discovery Antibiotics from WOCKHARDT gets Regulatory nod

MUMBAI | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals company Wockhardt Ltd said of having got Indian Regulatory approval for India’s first new discovery of antibiotics. The press-release titled, “India’s First New Discovery Antibiotics from Wockhardt Granted Indian Regulatory Approval”, enclosed with the regulatory filing as

JB CHEM clarifies on the confusion around Rantac®(Ranitidine)

MUMBAI | AHMEDABAD-GANDHINAGAR | RAJKOT – In a regulatory update as submitted to the Indian Stock Exchanges, Mumbai headquartered pharmaceuticals company JB Chemicals and Pharmaceuticals Ltd clarified on the reports having appeared in some sections of media indicating that their brand Rantac® (Ranitidine molecule) has been banned, which the company said was false and incorrect.

Torrent Pharma inks diabetic drug marketing pact with Glenmark Pharma

AHMEDABAD | MUMBAI | RAJKOT –  In a press release submitted to the Indian Bourses by Glenmark Pharma it said that, Ahmedabad headquartered Torrent Pharmaceuticals and Glenmark Pharmaceuticals Ltd have inked agreement for co-marketing of diabetic treatment drug Remogliflozin Etabonate in India. The press release submitted to the Indian Exchanges on Thursday read that, Glenmark

Do NOT follow this link or you will be banned from the site!